Matrix Metalloproteinase-2 Plays a Critical Role in the Pathogenesis of White Matter Lesions After Chronic Cerebral Hypoperfusion in Rodents
- 1 November 2006
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 37 (11), 2816-2823
- https://doi.org/10.1161/01.str.0000244808.17972.55
Abstract
Background and Purpose— Cerebrovascular white matter (WM) lesions contribute to cognitive impairment and motor dysfunction in the elderly. A disruption of the blood–brain barrier (BBB) is believed to be a critical early event leading to these WM lesions. Previous studies have suggested the involvement of matrix metalloproteinase-2 (MMP-2) in BBB disruptions and the upregulation of MMP-2 after chronic cerebral hypoperfusion in a rat model. In the present study, we asked whether MMP-2 is involved in the BBB disruption and the subsequent WM lesions after chronic cerebral hypoperfusion. Methods— We compared the severity of white matter lesions in rats after chronic cerebral hypoperfusion with or without an MMP inhibitor. Then, we also induced the chronic cerebral hypoperfusion in wild-type and MMP-2-null mice. Results— In the rats treated with a relatively selective MMP-2 inhibitor, AG3340, the WM lesions after chronic cerebral hypoperfusion were significantly less severe, and the number of activated astroglia and microglia were also significantly lower as compared with the vehicle-treated rats. Gene knockout of MMP-2 also reduced the severity of the WM lesions and the number of activated astroglia and microglia in a mice system. In both rodents, the disruption of BBB function, as assessed by IgM staining and the Evans blue extravasation test, was less severe when MMP-2 activity was attenuated. Conclusions— These findings indicate that MMP-2 plays a critical role in the BBB disruption, glial cell activation, and WM lesions after chronic cerebral hypoperfusion and suggest the potential value of MMP-2 inhibitors as a therapeutic tool in cerebrovascular WM lesions.Keywords
This publication has 19 references indexed in Scilit:
- Intracranial arterial dolichoectasia and small‐vessel disease in stroke patientsAnnals of Neurology, 2005
- MMP‐2 null mice exhibit an early onset and severe experimental autoimmune encephalomyelitis due to an increase in MMP‐9 expression and activityThe FASEB Journal, 2004
- Focal cerebral ischemia induces active proteases that degrade microvascular matrix.Stroke, 2004
- Role of Matrix Metalloproteinases in Delayed Neuronal Damage after Transient Global Cerebral IschemiaJournal of Neuroscience, 2004
- Activation Systems for Latent Matrix Metalloproteinase-2 are Upregulated Immediately after Focal Cerebral IschemiaJournal of Cerebral Blood Flow & Metabolism, 2003
- Profiles of Matrix Metalloproteinases, Their Inhibitors, and Laminin in Stroke PatientsStroke, 2003
- Blood–Brain Barrier Disruption in White Matter Lesions in a Rat Model of Chronic Cerebral HypoperfusionJournal of Cerebral Blood Flow & Metabolism, 2002
- Unaltered Secretion of β-Amyloid Precursor Protein in Gelatinase A (Matrix Metalloproteinase 2)-deficient MiceJournal of Biological Chemistry, 1997
- Proteolytic Cascade Enzymes Increase in Focal Cerebral Ischemia in RatJournal of Cerebral Blood Flow & Metabolism, 1996
- Cerebral circulation and oxygen metabolism associated with subclinical periventricular hyperintensity as shown by magnetic resonance imagingAnnals of Neurology, 1990